Key result
During the modified Oxford maneuver, sodium nitroprusside increased cerebral arterial inflow by 0.36 µmol/kg/s despite decreasing blood flow velocity, indicating middle cerebral artery dilation.
Why the study?
Does the modified Oxford maneuver (sodium nitroprusside followed by phenylephrine) alter middle cerebral artery diameter and cerebral oxygen delivery in healthy subjects?
Does the modified Oxford maneuver (sodium nitroprusside followed by phenylephrine) alter middle cerebral artery diameter and cerebral oxygen delivery in healthy subjects?
Absolute Event Rate: 0.36% vs 0%
p-value: p=<0.05
The study demonstrates that sodium nitroprusside dilates and phenylephrine constricts the middle cerebral artery, resolving the apparent discrepancy between transcranial Doppler and near-infrared spectroscopy measurements during the modified Oxford maneuver.
Alerts to MCA diameter changes affecting TCD flow estimates during baroreflex testing; leaves open translation to patients.
The modified Oxford maneuver is the reference standard for assessing arterial baroreflex function. The maneuver comprises a systemic bolus injection of 100 μg sodium nitroprusside (SNP) followed by 150 μg phenylephrine (PE). On the one hand, this results in an increase in oxyhemoglobin and total hemoglobin followed by a decrease within the cerebral sample volume illuminated by near-infrared spectroscopy (NIRS). On the other hand, it produces a decrease in cerebral blood flow velocity (CBFv) within the middle cerebral artery (MCA) during SNP and an increase in CBFv during PE as measured by transcranial Doppler ultrasound. To resolve this apparent discrepancy, we hypothesized that SNP dilates, whereas PE constricts, the MCA. We combined transcranial Doppler ultrasound of the right MCA with NIRS illuminating the right frontal cortex in 12 supine healthy subjects 18-24 yr old. Assuming constant O₂ consumption and venous saturation, as estimated by partial venous occlusion plethysmography, we used conservation of mass (continuity) equations to estimate the changes in arterial inflow (ΔQa) and venous outflow (ΔQv) of the NIRS-illuminated area. Oxyhemoglobin and total hemoglobin, respectively, increased by 13.6 ± 1.6 and 15.2 ± 1.4 μmol/kg brain tissue with SNP despite hypotension and decreased by 6 ± 1 and 7 ± 1 μmol/kg with PE despite hypertension. SNP increased ΔQa by 0.36 ± .03 μmol·kg(-1)·s(-1) (21.6 μmol·kg(-1)·min(-1)), whereas CBFv decreased from 71 ± 2 to 62 ± 2 cm/s. PE decreased ΔQa by 0.27 ± .2 μmol·kg(-1)·s(-1) (16.2 μmol·kg(-1)·min(-1)), whereas CBFv increased to 75 ± 3 cm/s. These results are consistent with dilation of the MCA by SNP and constriction by PE.
No takes yet. Share an insight, caveat, or question.
Stewart et al. (2013) studied Healthy subjects (n=12). Modified Oxford maneuver (Sodium nitroprusside followed by phenylephrine) vs. Baseline (supine rest) was evaluated on Change in NIRS-estimated cerebral arterial inflow (ΔQa) during sodium nitroprusside administration (p=<0.05). During the modified Oxford maneuver, sodium nitroprusside increased cerebral arterial inflow by 0.36 µmol/kg/s despite decreasing blood flow velocity, indicating middle cerebral artery dilation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: